Prospective Trial of Stereotactic Body Radiation Therapy for Both Operable and Inoperable T1N0M0 Non-Small Cell Lung Cancer: Japan Clinical Oncology Group Study JCOG0403.
about
Is surgery still the optimal treatment for stage I non-small cell lung cancer?A critical review of recent developments in radiotherapy for non-small cell lung cancerClinical outcomes of stage I and IIA non-small cell lung cancer patients treated with stereotactic body radiotherapy using a real-time tumor-tracking radiotherapy system.Clinical outcomes using carbon-ion radiotherapy and dose-volume histogram comparison between carbon-ion radiotherapy and photon therapy for T2b-4N0M0 non-small cell lung cancer-A pilot studyComparison of particle beam therapy and stereotactic body radiotherapy for early stage non-small cell lung cancer: A systematic review and hypothesis-generating meta-analysis.The impact of emphysema on dosimetric parameters for stereotactic body radiotherapy of the lung.Is it time for SABR to overtake surgery as the treatment of choice for stage I non-small cell lung cancer?Marginal prescription equivalent to the isocenter prescription in lung stereotactic body radiotherapy: preliminary study for Japan Clinical Oncology Group trial (JCOG1408)Enhancement of mTOR signaling contributes to acquired X-ray and C-ion resistance in mouse squamous carcinoma cell line.A systematic review of outcomes following stereotactic ablative radiotherapy in the treatment of early-stage primary lung cancer.Next-generation sequencing and clinical outcomes of patients with lung adenocarcinoma treated with stereotactic body radiotherapy.Stereotactic body radiotherapy versus lobectomy for operable clinical stage IA lung adenocarcinoma: comparison of survival outcomes in two clinical trials with propensity score analysis (JCOG1313-A).7-year follow-up after stereotactic ablative radiotherapy for patients with stage I non-small cell lung cancer: Results of a phase 2 clinical trial.Dosimetric factors predicting radiation pneumonitis after CyberKnife stereotactic body radiotherapy for peripheral lung cancerPredictive factors of symptomatic radiation pneumonitis in primary and metastatic lung tumors treated with stereotactic ablative body radiotherapyStereotactic body radiotherapy for stage I non-small-cell lung cancer using higher doses for larger tumors: results of the second study.Proton beam therapy in non-small cell lung cancer: state of the art.Clinical results of accelerated hypofractionated radiotherapy for central-type small lung tumours.Carbon-ion radiotherapy for non-small cell lung cancer with interstitial lung disease: a retrospective analysis.High Dose Hypofractionated Proton Beam Therapy is a Safe and Feasible Treatment for Central Lung Cancer.What is the role of stereotactic ablative radiotherapy in the management of surgically resectable and operable stage I non-small cell lung cancer?SBRT versus lobectomy in stage I NSCLC: knowns, unknowns and its interpretation.Systemic Inflammation Biomarkers Predict Survival in Patients of Early Stage Non-Small Cell Lung Cancer Treated With Stereotactic Ablative Radiotherapy - A Single Center Experience.Surgery or stereotactic body radiotherapy for elderly stage I lung cancer? A propensity score matching analysis.A phase I/II study on stereotactic body radiotherapy with real-time tumor tracking using CyberKnife based on the Monte Carlo algorithm for lung tumors.A randomized Phase III trial of comparing two dose-fractionations stereotactic body radiotherapy (SBRT) for medically inoperable Stage IA non-small cell lung cancer or small lung lesions clinically diagnosed as primary lung cancer: Japan Clinical OnPhase I study of stereotactic body radiation therapy for centrally located stage IA non-small cell lung cancer (JROSG10-1).Surgery versus stereotactic body radiation therapy for stage I non-small cell lung cancer: A comprehensive review.Clinical results of proton beam therapy for elderly patients with non-small cell lung cancer.Stereotactic Body Radiotherapy for Early-stage Non-small-cell Lung Cancer in Patients 80 Years and Older: A Multi-center Analysis.Nomograms for predicting disease progression in patients of Stage I non-small cell lung cancer treated with stereotactic body radiotherapy.Surgery for metachronous second primary lung cancer versus surgery for primary lung cancer: a propensity score-matched comparison of postoperative complications and survival outcomes.The great debate flashes: Surgery versus stereotactic body radiotherapy as the primary treatment of early-stage lung cancer.Long-Term Outcomes of Salvage Stereotactic Ablative Radiotherapy for Isolated Lung Recurrence of Non-Small Cell Lung Cancer: A Phase II Clinical Trial.Stereotactic Body Radiation Therapy for Pulmonary Oligometastases Arising from Non-lung Primaries in Patients Without Extrapulmonary Disease.Correlation of biologically effective dose and the tumor control in Stage I (<5 cm) non-small cell lung cancer with stereotactic ablative radiotherapy: a single institutional cohort study.Flattening filter-free technique in volumetric modulated arc therapy for lung stereotactic body radiotherapy: A clinical comparison with the flattening filter technique.Clarithromycin mitigates radiation pneumonitis in patients with lung cancer treated with stereotactic body radiotherapy.Guidelines for stereotactic body radiation therapy treatment of lung cancer highlight important research questions: what is the next step?Stereotactic body radiation therapy (SBRT) for early stage non-small cell lung cancer (NSCLC): contemporary insights and advances
P2860
Q26749371-B4D533A1-D859-456C-8C4B-8DD922EF172DQ28079625-2B7883B5-39E6-41DE-9D89-24A1EA4606E8Q30834087-A17199B8-28C8-486D-AA29-0D9CE621F47EQ33554464-99539E04-0E60-4B9A-9C19-E923486607FFQ36382039-2BF50FEA-CE0B-4D68-84C1-114295AC1DECQ37301100-94F7D89F-35AE-43CD-9E01-32C127AC48B0Q37583844-DDFD3660-8C2A-4FCE-8618-F327A5713B87Q37659318-375B4038-750E-4F7C-BC87-69828185F2A9Q38696970-D7303A30-A485-4568-8BC0-FC08D546AEEBQ38790915-7344A7D1-18B5-4D6D-8E57-08EFF3D5052BQ39369140-30C6F03B-F55D-4176-A86B-7E91CD517CDEQ39769743-7EC03A00-6364-4FA7-AB53-586CF10346E8Q40271942-EDB47CFA-F3FB-4541-A99F-CBFFE81D3828Q40496623-CC012C75-4BE7-4A92-97F8-9ABB8B6F46FEQ41067520-92EEE492-032E-4CA9-B44E-EE64B7755C34Q41273661-EB767B11-BC2D-40C7-8363-BE034F6F7D28Q41546002-2209190A-72A2-4819-9166-285718B5A0EEQ41559497-807CE4D3-BFDA-481C-96D8-6CC00EC9147DQ41595091-7B96366C-2D99-432A-A956-1ED964FD0958Q41678140-238CA8F8-478D-46E7-9C56-85246DDF529DQ42340577-DE39B189-7F8C-4EEE-9392-9679C3F1FDAEQ42384628-EB88603B-5075-4585-AC5F-1752B5CC0BD7Q47108053-25BB9034-BF58-4A28-8744-CB9030810F56Q47781280-63A382EE-C152-4792-A958-664E12D20251Q47877896-EA7D906D-C940-4E02-AACD-10985734EC98Q48015363-AA62F24B-1C22-4FF8-9CAB-2EBDD8A518E4Q48202266-041E3D05-45B1-48E7-BA07-F3A0786F8814Q48369218-A5B5EBC0-5C32-4FA8-B11D-66DB41EE45AEQ49286208-5BEBC3FC-3B92-4FB7-86A8-B26C987838CFQ49310050-65E12C8E-3A65-4FDF-9F41-950A2AD337B9Q49666975-E49A443F-D1E0-468C-BB72-3457C352A0EBQ49667868-7ADE6C33-A13C-4ED3-8AC5-90A41B6E6425Q50138849-CCDAB27E-A48F-4F98-9DBC-D9CF42341930Q50862063-D26EF84D-5B82-48F5-8217-3370CE0EDEA5Q52592765-4FB8A2EC-15C8-43DD-8123-4DBC41E5CC53Q52763791-06AD4D18-8532-41BA-8812-504C801CA510Q55110451-65B018B4-F249-4EB4-B992-846FA65BB3B1Q55315278-EFACB5EF-A627-40D8-9CCC-B06076B6DE75Q55345592-EBDA71E7-921D-4D9A-9161-E954B36293DDQ57172947-5D5DB861-485B-4C99-A41B-EDF774246C63
P2860
Prospective Trial of Stereotactic Body Radiation Therapy for Both Operable and Inoperable T1N0M0 Non-Small Cell Lung Cancer: Japan Clinical Oncology Group Study JCOG0403.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Prospective Trial of Stereotac ...... Oncology Group Study JCOG0403.
@en
type
label
Prospective Trial of Stereotac ...... Oncology Group Study JCOG0403.
@en
prefLabel
Prospective Trial of Stereotac ...... Oncology Group Study JCOG0403.
@en
P2093
P1476
Prospective Trial of Stereotac ...... Oncology Group Study JCOG0403.
@en
P2093
Etsuo Kunieda
Hiroshi Onishi
Katsuyuki Karasawa
Kazushige Hayakawa
Keiichi Nakagawa
Masahiro Hiraoka
Masaki Kokubo
Masato Hareyama
Norio Mitsuhashi
Satoshi Ishikura
P304
P356
10.1016/J.IJROBP.2015.07.2278
P407
P577
2015-11-11T00:00:00Z